0001209191-20-045951.txt : 20200810
0001209191-20-045951.hdr.sgml : 20200810
20200810163339
ACCESSION NUMBER: 0001209191-20-045951
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200806
FILED AS OF DATE: 20200810
DATE AS OF CHANGE: 20200810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Demski David M
CENTRAL INDEX KEY: 0001555392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 201089866
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-06
0
0001237831
GLOBUS MEDICAL INC
GMED
0001555392
Demski David M
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
1
0
0
President, CEO
Class A Common Stock
2020-08-06
4
M
0
173750
29.31
A
173750
D
Class A Common Stock
2020-08-06
4
M
0
96875
43.77
A
270625
D
Class A Common Stock
2020-08-06
4
M
0
59375
43.58
A
330000
D
Class A Common Stock
2020-08-06
4
S
0
96900
55.42
D
233100
D
Class A Common Stock
2020-08-06
4
S
0
68100
56.24
D
165000
D
Class A Common Stock
2020-08-06
4
S
0
165000
57.02
D
0
D
Stock Option (Right to Buy Class A Common Stock)
29.31
2020-08-06
4
M
0
173750
0.00
D
2027-08-28
Class A Common Stock
173750
126250
D
Stock Option (Right to Buy Class A Common Stock)
43.77
2020-08-06
4
M
0
96875
0.00
D
2028-01-22
Class A Common Stock
96875
53125
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2020-08-06
4
M
0
59375
0.00
D
2029-01-22
Class A Common Stock
59375
90625
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.995, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.97, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months
These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Kelly G. Huller, Attorney-in-Fact
2020-08-10
EX-24.4_932554
2
poa.txt
POA DOCUMENT
Know all by these presents that the undersigned hereby constitutes and appoints
each of Kelly G. Huller and Adam M. Cole, and each of them acting alone, signing
singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for
and on behalf of the undersigned, in the undersigned's capacity as an officer,
director and/or 10% or more stockholder of Globus Medical, Inc. (the "Company"),
Forms ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments
thereto) in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the "1934 Act"), and the rules promulgated thereunder; (2) do
and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form ID, 3, 4, 5 and
Update Passphrase Acknowledgement (and any amendments thereto) and to file
timely such form with the United States Securities and Exchange Commission and
any stock exchange or similar authority; and (3) take any other action of any
type whatsoever in connection with the foregoing which in the opinion of such
attorney-in-fact may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act.
This Power of Attorney revokes any and all prior powers of attorney and shall
remain in full force and effect until the undersigned is no longer required to
file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 18 day of February 2020.
/s/ David M. Demski
David M. Demski